ArticleJournal of orthopaedic case reports2026
Management of Relapsed, Residual, and Resistant Idiopathic Congenital Talipes Equinovarus.
Article in Journal of orthopaedic case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Comprehensive Analysis and Surgical Management of Neglected Congenital Talipes Equinovarus Using the Joshi's External Stabilizing System: A 3-Year Longitudinal Case Study and Biomechanical Review.Journal of orthopaedic case reports · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Congenital talipes equinovarus (CTEV) is a common pediatric deformity, with conservative management being the primary method of management. Even with appropriate management of CTEV, relapses can still occur, and some cases may present with residual deformities or prove resistant to treatment. The cause of these conditions is multifactorial, and there exists a difference of opinion regarding the management of such cases. The study aimed to provide clinically relevant outcome data in this specific and less frequently encountered population. The relatively small sample reflects the rarity of idiopathic relapsed, residual, and resistant CTEV and provides valuable preliminary data to guide future larger studies. Materials and Methods: This prospective, descriptive, observational study included 33 clubfeet in 25 patients presenting with relapsed, residual, or resistant CTEV between July 2022 and June 2024. Patients were treated with either Ponseti's method, including serial manipulation, casting, and tendo-achilles tenotomy, or Joshi's external stabilization system (JESS), a minimally invasive external fixation technique. Pre- and post-correction outcomes were assessed using the Pirani and Dimeglio scoring systems. Data on treatment compliance, complications, and outcomes were analyzed. Results: The mean age of patients was 44.6 months, ranging from 9 months to 8 years. Among 33 feet, 19 were classified as relapsed (59%), 9 as residual (28%), and 5 as resistant CTEV (13%). Ponseti's method was used for 45.45% of feet, and JESS for 54.55%. Post-correction Pirani scores improved significantly (mean pre-correction 4.11, post-correction 0.55; P < 0.001). Similarly, Dimeglio's scores improved (mean pre-correction 13.22, post-correction 2.88; P < 0.001). Complications were minimal and manageable, including cast slippage and pin-tract infections. JESS demonstrated superior outcomes for older children with more severe deformities. Conclusion: Both Ponseti's method and JESS are effective for managing relapsed, residual, and resistant CTEV, with JESS particularly beneficial for older children. Recurrence is commonly associated with inadequate bracing and follow-up. Comprehensive management, including early treatment, patient education, and consistent follow-up, is crucial for achieving and maintaining correction.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.